Chemed Corporation
CHE
$595.74
$1.390.23%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 639.99M | 606.18M | 595.88M | 589.23M | 585.91M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 639.99M | 606.18M | 595.88M | 589.23M | 585.91M |
| Cost of Revenue | 405.88M | 396.19M | 389.75M | 385.13M | 358.35M |
| Gross Profit | 234.12M | 209.99M | 206.13M | 204.11M | 227.57M |
| SG&A Expenses | 104.25M | 101.98M | 102.26M | 115.87M | 100.44M |
| Depreciation & Amortization | 15.83M | 15.70M | 15.71M | 15.81M | 15.54M |
| Other Operating Expenses | -288.00K | 159.00K | 37.00K | 92.00K | -2.06M |
| Total Operating Expenses | 525.67M | 514.02M | 507.76M | 516.90M | 472.26M |
| Operating Income | 114.32M | 92.16M | 88.13M | 72.33M | 113.66M |
| Income Before Tax | 120.12M | 101.03M | 93.83M | 84.49M | 115.59M |
| Income Tax Expenses | 29.80M | 25.25M | 22.94M | 19.47M | 25.54M |
| Earnings from Continuing Operations | 90.32M | 75.78M | 70.89M | 65.02M | 90.05M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 90.32M | 75.78M | 70.89M | 65.02M | 90.05M |
| EBIT | 114.32M | 92.16M | 88.13M | 72.33M | 113.66M |
| EBITDA | 125.86M | 107.85M | 103.84M | 88.14M | 124.69M |
| EPS Basic | 6.08 | 5.04 | 4.70 | 4.30 | 5.96 |
| Normalized Basic EPS | 5.07 | 4.20 | 3.88 | 3.49 | 4.88 |
| EPS Diluted | 6.03 | 5.00 | 4.65 | 4.24 | 5.90 |
| Normalized Diluted EPS | 5.03 | 4.16 | 3.85 | 3.44 | 4.82 |
| Average Basic Shares Outstanding | 14.85M | 15.03M | 15.10M | 15.12M | 15.10M |
| Average Diluted Shares Outstanding | 14.99M | 15.17M | 15.25M | 15.34M | 15.27M |
| Dividend Per Share | 0.50 | 0.50 | 0.40 | 0.40 | 0.40 |
| Payout Ratio | 8.30% | 9.88% | 8.54% | 9.31% | 6.72% |
